Outside fibroblasts play a key role in the development of inner neointima after the implantation of polytetrafluoroethylene grafts

Journal of Pharmacological Sciences

Volumn 119, Issue 2, 2012, Pages 139-149

  Jin, Denan ^a   Takai, Shinji ^a   Li, Zhonglian ^a   Sakonjo, Hiroshi ^b   Otsuki, Yoshinori ^a   Shibayama, Yuro ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Nissei BILIS   (Japan)

Author keywords

Chymase; Fibroblast migration; Grasil graft; Intima; Polytetrafluoroethylene graft

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CHYMASE; DESMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POLITEF; SMOOTHELIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY ANASTOMOSIS; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DOG; FIBROBLAST; GRAFT PATENCY; HEMODIALYSIS; HISTOPATHOLOGY; IMMUNOHISTOLOGY; MALE; NEOINTIMA; NONHUMAN; POROSITY; PROSTHESIS; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THROMBUS; VASCULAR ACCESS; VEIN ANASTOMOSIS;

EID: 84863109871     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11242FP     Document Type: Article

References (28)

1. Schwab SJ. Vascular access for hemodialysis. Kidney Int. 1999; 55:2078-2090. (Pubitemid 29198003)
2. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation. 1989;80:1726-1736. (Pubitemid 20031704)
3. Jin D, Ueda H, Takai S, Muramatsu M, Furubayashi K, Ibaraki T, et al. Roles of chymase in stenosis occurring after polytetrafluoroethylene graft implantations. Life Sci. 2007;81:1291-1300. (Pubitemid 47539509)
4. Ota K, Tsuji Y, Kukita K, Sasaki S, Sakai S, Fuchinoue S, et al. [Feature and clinical use report of Terumo graft for hemodialysis (TRE-687)]. J Jpn Soc Dial Ther. 2003;36:1693-1699. (text in Japanese with English abstract)
5. Ota K, Tsuji Y, Kukita K, Sasaki S, Sakai S, Fuchinoue S, et al. [Long-term outcome of Terumo vascular graft (GRASILR) for hemodialysis]. J Jpn Soc Dial Ther. 2006;39:1395-1401. (text in Japanese with English abstract)
6. Jin D, Ueda H, Takai S, Okamoto Y, Muramatsu M, Sakaguchi M, et al. Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs. J Am Soc Nephrol. 2005;16:1024-1034. (Pubitemid 41710313)
7. Takai S, Jin D, Ohzu M, Tanaka K, Miyazaki M. Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes. J Pharmacol Sci. 2009;110: 459-565.
8. Wang N, Stamenovic D. Mechanics of vimentin intermediate filaments. J Muscle Res Cell Motil. 2002;23:535-540. (Pubitemid 36583670)
9. Tomasek JJ, McRae J, Owens GK, Haaksma CJ. Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factorbeta1 control element. Am J Pathol. 2005;166:1343-1351. (Pubitemid 40586506)
10. Paulin D, Li Z. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res. 2004;301:1-7. (Pubitemid 39388889)
11. van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, van Eys GJ. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol. 1996;134:401-411. (Pubitemid 26250708)
12. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664. (Pubitemid 26320272)
13. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol. 2001;21:739-745. (Pubitemid 32448762)
14. Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, et al. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant. 2007;22:3139-3146. (Pubitemid 350202566)
15. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger JR, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation. 1993;87:283-290. (Pubitemid 23019359)
16. Fernandez-Alfonso MS, Martorana PA, Licka I, van Even P, Trobisch D, Schölkens BA, et al. Early induction of angiotensin I-converting enzyme in rat carotid artery after balloon injury. Hypertension. 1997;30:272-277. (Pubitemid 27329009)
17. Ohishi M, Ueda M, Rakugi H, Okamura A, Naruko T, Becker AE, et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation. 1997;96: 3328-3337. (Pubitemid 27513402)
18. Liu SQ. Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow. Arterioscler Thromb Vasc Biol. 1999;19:2630-2639. (Pubitemid 29536037)
19. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
20. Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245: 186-188. (Pubitemid 19193936)
21. Kauffman RF, Bean JS, Zimmerman KM, Brown RF, Steinberg MI. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci. 1991;49:PL223-PL228.
22. Gradzki R, Dhingra RK, Port FK, Roys E, Weitzel WF, Messana JM. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts. Am J Kidney Dis. 2001;38:1240-1244. (Pubitemid 34193109)
23. Sajgure A, Choudhury A, Ahmed Z, Choudhury D. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency. Nephrol Dial Transplant. 2007;22:1390-1398. (Pubitemid 47072228)
24. Reilly CF, Tewksbury DA, Schechter NM, Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem. 1982;257:8619-8622. (Pubitemid 12004182)
25. Takai S, Shiota N, Kobayashi S, Matsumura E, Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett. 1997;412:86-90. (Pubitemid 27310005)
26. Takai S, Jin D, Miyazaki M. New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage. J Pharmacol Sci. 2010;113: 301-309.
27. Yurt R, Austen KF. Preparative purification of the rat mast cell chymase: characterization and interaction with granule components. J Exp Med. 1977;146:1405-1419. (Pubitemid 8218419)
28. Dzau VJ. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol. 1984;6 Suppl 2:S377-S382.